These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19515475)

  • 1. Kidney function and volume progression in unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis or hypoplasia: a case series.
    Poster D; Kistler AD; Krauer F; Blumenfeld JD; Rennert H; Weishaupt D; Wüthrich RP; Serra AL
    Am J Kidney Dis; 2009 Sep; 54(3):450-8. PubMed ID: 19515475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral autosomal dominant polycystic kidney disease with contralateral renal agenesis: a case report.
    Jeong GH; Park BS; Jeong TK; Ma SK; Yeum CH; Kim SW; Kim NH; Choi KC
    J Korean Med Sci; 2003 Apr; 18(2):284-6. PubMed ID: 12692431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.
    Serra AL; Poster D; Kistler AD; Krauer F; Raina S; Young J; Rentsch KM; Spanaus KS; Senn O; Kristanto P; Scheffel H; Weishaupt D; Wüthrich RP
    N Engl J Med; 2010 Aug; 363(9):820-9. PubMed ID: 20581391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus in patients with autosomal dominant polycystic kidney disease.
    Walz G; Budde K; Mannaa M; Nürnberger J; Wanner C; Sommerer C; Kunzendorf U; Banas B; Hörl WH; Obermüller N; Arns W; Pavenstädt H; Gaedeke J; Büchert M; May C; Gschaidmeier H; Kramer S; Eckardt KU
    N Engl J Med; 2010 Aug; 363(9):830-40. PubMed ID: 20581392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging progression in polycystic kidney disease.
    Perrone R
    N Engl J Med; 2006 May; 354(20):2181-3. PubMed ID: 16707757
    [No Abstract]   [Full Text] [Related]  

  • 6. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
    Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
    Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.
    Lee YR; Lee KB
    Nephron Clin Pract; 2006; 103(4):c173-80. PubMed ID: 16636585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.
    Fick-Brosnahan GM; Belz MM; McFann KK; Johnson AM; Schrier RW
    Am J Kidney Dis; 2002 Jun; 39(6):1127-34. PubMed ID: 12046022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of eicosapentaenoic acid on renal function and volume in patients with ADPKD.
    Higashihara E; Nutahara K; Horie S; Muto S; Hosoya T; Hanaoka K; Tuchiya K; Kamura K; Takaichi K; Ubara Y; Itomura M; Hamazaki T
    Nephrol Dial Transplant; 2008 Sep; 23(9):2847-52. PubMed ID: 18372389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Variable progression of autosomal dominant polycystic kidney disease: genetic and molecular counterparts].
    Devuyst O
    Nephrol Ther; 2006 Jan; 2 Suppl 2():S104-8. PubMed ID: 17373208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
    Devuyst O
    J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volume progression in polycystic kidney disease.
    Brosnahan GM
    N Engl J Med; 2006 Aug; 355(7):733; author reply 733-4. PubMed ID: 16914712
    [No Abstract]   [Full Text] [Related]  

  • 14. Interpretation of renal volume in autosomal dominant polycystic kidney disease and relevant clinical implications.
    Masoumi A; Elhassan E; Schrier RW
    Iran J Kidney Dis; 2011 Jan; 5(1):1-8. PubMed ID: 21189426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergent early markers of renal progression in autosomal-dominant polycystic kidney disease patients: implications for prevention and treatment.
    Helal I; Reed B; Schrier RW
    Am J Nephrol; 2012; 36(2):162-7. PubMed ID: 22846584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian target of rapamycin and autosomal dominant polycystic kidney disease.
    Wüthrich RP; Serra AL
    Transplant Proc; 2009; 41(6 Suppl):S18-20. PubMed ID: 19651290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease.
    Lacquaniti A; Chirico V; Lupica R; Buemi A; Loddo S; Caccamo C; Salis P; Bertani T; Buemi M
    Peptides; 2013 Nov; 49():1-8. PubMed ID: 23973863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
    Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
    Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.